Document is current

Article History

Received: 5 March 2025

Accepted: 25 May 2025

First Online: 3 July 2025

Declarations

:

: GL Olmes received grants form AstraZeneca (Cambridge, UK), Medconcept (Neustadt an der Weinstraße, Germany), University Medical Center Freiburg (Germany), Der PRIVATARZT Gynäkologie (MiM Verlagsgesellschaft mbH, Neu-Isenburg, Germany) and RG Ärztefortbildung GmbH, membership of DGGG (Berlin, Germany), AGE (Buchholz, Germany), and AGEM (Berlin, Germany) and scientific colloboration with Karl Storz (Tuttlingen, Germany). MP Nigdelis received honoraria from RG Ärztefortbildung GmbH, as well as travel grants from Organon (Jersey City, USA). B Haj Hamoud received travel grants from Gedeon Richter, AstraZeneca (Cambridge, UK); Johnson & Johnson (New Brunswick, NJ, USA) and Storz (Tuttlingen, Germany) and is member of DGGG (Berlin, Germany), AGE (Buchholz, Germany) and Stiftung Endometriose Forschung (Westerstede, Germany) EF Solomayer is receiving: grants from the University of Saarland, and Storz and Erbe; personal fees and other compensation from Roche (Basel, Switzerland), Pfizer (New York City, NY, USA), Celgene (Summit USA), Amgen (Thousand Oaks, CA, USA), and Astra Zeneca (Cambridge, UK); and other fees from Esai (Tokyo, Japan), Johnson & Johnson (New Brunswick, NJ, USA), Novartis (Basel, Switzerland), Tesaro (Waltham, MA, USA), Teva (Petach Tikwa, Israel), Medac GmbH (Wedel, Germany), MSD (Kenilworth, NJ, USA), Vifor (Sankt Gallen, Switzerland), Gedeon Richter (Budapest, Hungary), Takeda (Tokyo, Japan), and AGE (Buchholz, Germany); other potential conflicts: Clovis Oncology (Boulder, Colorado, USA), Genomic Health (Redwood City, California, USA), Jenapharm (Jena, Germany), Matramed (Bexbach, Germany), Mentor (Minneapolis, Minnesota, USA), Pharma Mar (Mardid, Spain), Samsung (Suwon, Southkorea), University of Saarland (Saarbrücken, Germany), DGGG (Berlin, Germany), AGO (Taufkirchen, Germany), AGUB (Taufkirchen, Germany), DGS (Berlin, Germany), DKG (Berlin, Germany), Saarländisches Tumorzentrum am UKS e.V., University of Saarland, Homburg, Germany), Saarländische Krebsgesellschaft (Saarbrücken, Germany), Stiftung Endometriose Forschung (Westerstede, Germany), ESGE (Leuven, Belgium), ETC (Saarbrücken, Germany), DEGUM (Berlin, Germany), Deutsche Kontinenzgesellschaft (Frankfurt, Germany), BLFG (Berlin, Germany), Medconcept (Neustadt an der Weinstraße, Germany), Thieme (Stuttgart, Germany). M Bewarder received honoraria from AstraZeneca, Janssen and BMS. JT Bittenbring received personal fees from Roche, Abbvie, Kite-Gilead, BMS, Al, AstraZeneca and Sobi and grants from Lilly, Tilray and Grünenthal. N Kranzhöfer received travel grants and other fees from Celgene (Summit, USA), Astra Zeneca (Cambridge, UK), Sandoz (Basel, Schweiz), Janssen Cilag (Neuss, Germany), Beigene (New Jersey, USA), GSK (Philadelphia, USA), Stemline Therapeutics GmbH New York City, USA) M Doerk received travel grants from Gedeon Richter (Budapest, Hungary), Organon (Jersey City, USA) and Eisai (Tokyo, Japan) and is a member of DGGG (Berlin, Germany), AGE (Buchholz, Germany), Deutsche Gesellschaft für Senologie (Berlin, Germany). L Thurner, YJ Kim and A Seibold declare no conflict of interest according to the manuscript.

: Treatment followed standard of care.

: Treatment followed the standard of care.

: Written informed consent was obtained from the patient for publication of this case report.